跳至主要内容
临床试验/SLCTR/2019/035
SLCTR/2019/035招募中3 期

Effectiveness of modified Whitfield’s ointment with oral griseofulvin in the treatment of dermatophytosis poorly responsive to standard treatment: A randomized, double-blind, within-patient-placebo-controlled clinical trial

niversity of Peradeniya, Peradeniya.0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Both male and female
  • 2. Age more than 18 years
  • 3. Clinically confirmed dermatophytosis, poorly responsive to standard antifungal therapy (dermatophytosis for a duration of 3 months or more which has been treated with 2 or more systemic antifungals).
  • 4. Presence of two or more skin lesions of dermatophytosis

排除标准

  • 1. Contraindications for griseofulvin such as chronic liver disease, porphyria, SLE exacerbation
  • 2. Patients who are on drugs that may lead to potential drug interactions with griseofulvin
  • 3. Patients who have a history of adverse reactions to the ingredients of the modified Whitfield’s ointment
  • 4. Pregnancy (Excluded by the last menstrual period, if unsure of the menstrual dates, treatment will be commenced after the next menstrual period)
  • 5. Breast feeding
  • 6. Patients with lesions involving the nails and scalp only.

研究者

发起方
niversity of Peradeniya, Peradeniya.

相似试验